Cytek Biosciences, Inc. (CTKB) reported revenue at $57.5 million

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported revenue for the quarter came in at $57.5 million versus the consensus estimate of $61.49 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
• Jefferies Financial Group (JEF) Misses Q2 EPS by 22c
• Barclays Upgrades United Internet AG (UTDI:GR) (UDIRY) to Overweight